Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
BaCkground
Essential tremor (ET) is a common movement disorder. It is characterised by a postural and kinetic tremor of the arms and other parts of the body; its progression is slow but can lead to an impairment of the activities the patient plays in a typical day at home and at work. 1 The primary cause and the pathogenesis of the symptoms are unknown.
The prevalent involvement seems to be the cerebellar one. It is accompanied by a dysfunction of cerebellar-thalamic-cortical circuits. 2 The various symptomatic therapies available (eg, propranolol, primidone, and so on) are not always effective and often give side effects which require some adjustments to the treatment or its interruption. 3 No biochemical studies on the carbohydrate metabolism of neurons affected by the disease are reported in literature. However, studies conducted with F-18-fluorodeoxyglucose-positron emission tomography have found a glucose hypometabolism in the centres whose dysfunction causes the ET. 4 5 It is well established that thiamine plays a key role in the glucose metabolism, in maintaining brain functions and that thiamine deficiency (TD) causes beriberi and Wernicke-Korsakoff syndrome. Recent studies have found that thiamine is implicated in oxidative stress, peroxisomal function, protein processing, gene expression and calcium-dependent processes. 6 7 In the hypothesis that glucose hypometabolism was due to a dysfunction of thiamine-dependent processes, and that energetic hypometabolism would play an important role in the pathogenesis of the symptoms, we treated two patients affected by ET with intramuscular high-dose thiamine. 8 Patients have signed a consent both to start the treatment and to publish its results. Video recordings documenting the experience are attached to this study.
CaSe preSenTaTion
The diagnosis of ET is based on clinical history and physical examination.
Starting in 2014, we evaluated and treated with intramuscular high-dose thiamine some patients affected by ET. ET had been diagnosed by expert neurologists according to diagnostic criteria for ET described by Deuschl et al in 1998. 9 The first in time two patients we treated are the subjects of this study. None of the patients had ever been treated with the symptomatic therapies available.
We evaluated the patients with The Essential Tremor Rating Assessment Scale (TETRAS). 10 TETRAS is composed of two subscales: Activities of Daily Living Subscale (ADLS) and the Performance Subscale (PS) (see table 1 ).
The patients were evaluated before the beginning of the treatment. Evaluation was only clinical. The follow-ups have been performed 3 months after the beginning of the treatment. Patient 1. Male, 73 years old, with a weight of 68 kg, affected by diabetes mellitus (in treatment with the oral antidiabetic metformin 500 mg twice a day) for some 10 years. The tremor started at the age of 68 with slight right-hand tremor, with difficulty in the handwriting. Later on, also his head and Video 1 Patient 1 before the therapy The ADLS score was 17 points, PS score was 19.5 points (see table 1 ).
Patient 2. Female, 75 years old, with a weight of 70 kg, no other diseases reported. The postural and kinetic tremor started at the age of 69. She realised that, while decorating objects with tools, her right hand had a very fine tremor. Afterwards she began to have growing difficulties in her decorating work. The patient, at the end of November 2014, at the age of 72, started treatment with an intramuscular injection of 100 mg of thiamine twice a week. There was no case of ET in her family history. Neurological examination was normal except for the postural and kinetic tremor of the head and hands. 
diSCuSSion
With intramuscular administration of thiamine, patients showed significant improvement of the symptoms of ET. It is common Findings that shed new light on the possible pathogenesis of a disease or an adverse effect evidence that in the presence of TD the patient's response to therapy is diagnostic. 11 The intramuscular high-dose thiamine, through passive diffusion transport, by increasing the concentration of the molecule within the cells, seems to restore the function of thiamine-dependent mechanisms in the centres responsible for motor dysfunction resulting in improvements of the tremor. Enzymatic abnormalities or dysfunction of the circulation of thiamine in the intracellular space may cause intracellular TD with normal plasma values. 12 It is worth mentioning that being metformin an inhibitor of the human thiamine transporter, THTR-2 (SLC19A3), this drug may be the cause of TD with normal blood thiamine. [13] [14] [15] The perturbed intracellular transport of thiamine due to metformin treatment may play a role in the genesis of the thiamine-responsive ET in patient 1. We could not measure the intracellular levels of erythrocytic transketolase activity without and with thiamine diphosphate because such test is not available in Italy. Such an exam would indeed be a useful aid to study the intracellular TD.
Our clinical observation led to suppose that symptoms featuring ET could derive from a focal, intracellular TD that determines a selective neuronal dysfunction. In other words, TD could have an important role in the pathogenesis of the symptoms of ET. The administration of large quantities of intramuscular vitamin B1 increases the intracellular passive transport of the thiamine and symptoms decrease when the glucose metabolism and other thiamine-dependent processes are led back to physiologic levels.
Disorders of thiamine transporter genes that lead to neurological damage can be treated with high-dose thiamine. 12 16 Recently, some authors achieved good results in sporadic degenerative diseases with the same treatment. 17 The exact mechanism of thiamine responsiveness in these patients is unknown. The patients reported an improvement of the symptoms. As we are writing this report (about 3 years have passed since the beginning of the treatment), they are continuing the same therapy and still have the same improved motor conditions, without any side effect. Thus, it seems that the therapy may play an important role in limiting the progression of the disease and we deem necessary a lifelong use of high-dose thiamine in affected subjects. No side effects have been reported in patients treated with high doses of thiamine, without interruption, even for years. 17 18 In conclusion, we hope that this report raises interest in the scientific community and leads to other studies that can confirm the present observation.
learning points
► Intramuscular administration of thiamine appears to be highly effective for the treatment of essential tremor. ► Metformin can cause thiamine deficiency. ► The use of thiamine is also safe for prolonged treatments over time. ► The improvement of the symptoms, while continuing the treatment, persists over time. Thiamine could have a restorative and neuroprotective effect on the neurons of affected nerve centres.
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Video 4 Patient 1 two years after therapy
Video 5 Patient 1 three years after therapy 
